N/A
Completed N=302
Retrospective Chart Review of enVista Toric 0.9D Intraocular Lenses
Corneal Astigmatism
Source: ClinicalTrials.gov NCT05075746 ↗
Enrolled (actual)
302
Serious AEs
0.0%
Results posted
Mar 2024
Primary outcomePrimary: Mean Reduction in Cylindrical Power of the Eye — 0.432; 0.071 Diopters
Summary
The primary objective of this study is to evaluate the performance of the enVista Toric 0.9D vs non-Toric IOL.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Mean Reduction in Cylindrical Power of the Eye |
0.432; 0.071 | — |
Eligibility Criteria
Inclusion Criteria
- Males and Females subjects age 18 or older on the date of surgery
- Implant of enVista Toric IOL and/or enVista non-Toric (spherical) IOL in at least one eye
- Data available at least 4 weeks after IOL implantation
- Eyes must qualify for the 0.9D toric lens based on the Barrett Toric Calculator (flipped axis must be less than 0.2D) (https://ascrs.org/tools/barrett-toric-calculator)
- Study eyes were implanted with the 0.9D toric lens
- Control eyes were not implanted with the 0.9D toric lens and implanted with a spherical (non-toric) equivalent instead
Exclusion Criteria
- History of uncontrolled or clinically significant ocular comorbidities for the treated eye(s) before the surgery (e.g., dry eyes, retinal pathology, etc.)
- BCDVA of 20/25 or worse for the treated eye(s) after the surgery
- Excessive IOL rotation > 10 degrees (Toric IOLs only) for the treated eye(s) after the surgery
Data sourced from ClinicalTrials.gov (NCT05075746). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.